BioCentury
ARTICLE | Clinical News

Encapsulated pancreatic islet cells data

January 16, 1995 8:00 AM UTC

The Santa Monica, Calif., company reported Phase I/II results from two patients of the 20 to be enrolled, showing maintenance of tight control over levels of blood glucose.

As presented at the International Conference on Cellular Therapy and Tissue Engineering in Washington, D.C., tight control was maintained, and islet cells continued to function, for 19 months to date following an injection of the cells. ...